TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway

Abstract In this study, we investigate the G2 checkpoint activated by chromosome entanglements, the so-called Decatenation Checkpoint (DC), which can be activated by TOP2A catalytic inhibition. Specifically, we focus on the spontaneous ability of cells to bypass or override this checkpoint, referred...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria C. Arroyo López, M. A. Fernández-Mimbrera, E. Gollini, A. Esteve-Codina, A. Sánchez, Juan Alberto Marchal Ortega
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87895-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571777583153152
author Maria C. Arroyo López
M. A. Fernández-Mimbrera
E. Gollini
A. Esteve-Codina
A. Sánchez
Juan Alberto Marchal Ortega
author_facet Maria C. Arroyo López
M. A. Fernández-Mimbrera
E. Gollini
A. Esteve-Codina
A. Sánchez
Juan Alberto Marchal Ortega
author_sort Maria C. Arroyo López
collection DOAJ
description Abstract In this study, we investigate the G2 checkpoint activated by chromosome entanglements, the so-called Decatenation Checkpoint (DC), which can be activated by TOP2A catalytic inhibition. Specifically, we focus on the spontaneous ability of cells to bypass or override this checkpoint, referred to as checkpoint adaptation. Some factors involved in adapting to this checkpoint are p53 and MCPH1. Using cellular models depleted of p53 or both p53 and MCPH1 in hTERT-RPE1 cells, we analyzed cell cycle dynamics and adaptation, segregation defects, apoptosis rate, and transcriptional changes related to prolonged exposure to TOP2A inhibitors. Our findings reveal that cell cycle dynamics are altered in MCPH1-depleted cells compared to control cells. We found that MCPH1 depletion can restore the robustness of the DC in a p53-negative background. Furthermore, this research highlights the differential effects of TOP2A poisons and catalytic inhibitors on cellular outcomes and transcriptional profiles. By examining the different mechanisms of TOP2A inhibition and their impact on cellular processes, this study contributes to a deeper understanding of the regulation and physiological implications of the DC and checkpoint adaptation in non-carcinogenic cell lines.
format Article
id doaj-art-2de56321e0ff4c698d4d28f739c45a9a
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2de56321e0ff4c698d4d28f739c45a9a2025-02-02T12:18:25ZengNature PortfolioScientific Reports2045-23222025-01-0115111910.1038/s41598-025-87895-8TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathwayMaria C. Arroyo López0M. A. Fernández-Mimbrera1E. Gollini2A. Esteve-Codina3A. Sánchez4Juan Alberto Marchal Ortega5Cell Biology and Epigenetics, Department of Biology, Technical University of DarmstadtDepartamento Biología Experimental, Universidad de JaénDepartamento Biología Experimental, Universidad de JaénCentre Nacional d’Anàlisi Genòmica (CNAG)Departamento Biología Experimental, Universidad de JaénDepartamento Biología Experimental, Universidad de JaénAbstract In this study, we investigate the G2 checkpoint activated by chromosome entanglements, the so-called Decatenation Checkpoint (DC), which can be activated by TOP2A catalytic inhibition. Specifically, we focus on the spontaneous ability of cells to bypass or override this checkpoint, referred to as checkpoint adaptation. Some factors involved in adapting to this checkpoint are p53 and MCPH1. Using cellular models depleted of p53 or both p53 and MCPH1 in hTERT-RPE1 cells, we analyzed cell cycle dynamics and adaptation, segregation defects, apoptosis rate, and transcriptional changes related to prolonged exposure to TOP2A inhibitors. Our findings reveal that cell cycle dynamics are altered in MCPH1-depleted cells compared to control cells. We found that MCPH1 depletion can restore the robustness of the DC in a p53-negative background. Furthermore, this research highlights the differential effects of TOP2A poisons and catalytic inhibitors on cellular outcomes and transcriptional profiles. By examining the different mechanisms of TOP2A inhibition and their impact on cellular processes, this study contributes to a deeper understanding of the regulation and physiological implications of the DC and checkpoint adaptation in non-carcinogenic cell lines.https://doi.org/10.1038/s41598-025-87895-8TOP2A inhibitionICRF193G2 checkpointCheckpoint adaptationMCPH1Microscopy
spellingShingle Maria C. Arroyo López
M. A. Fernández-Mimbrera
E. Gollini
A. Esteve-Codina
A. Sánchez
Juan Alberto Marchal Ortega
TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
Scientific Reports
TOP2A inhibition
ICRF193
G2 checkpoint
Checkpoint adaptation
MCPH1
Microscopy
title TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
title_full TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
title_fullStr TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
title_full_unstemmed TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
title_short TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
title_sort top2a inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
topic TOP2A inhibition
ICRF193
G2 checkpoint
Checkpoint adaptation
MCPH1
Microscopy
url https://doi.org/10.1038/s41598-025-87895-8
work_keys_str_mv AT mariacarroyolopez top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway
AT mafernandezmimbrera top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway
AT egollini top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway
AT aestevecodina top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway
AT asanchez top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway
AT juanalbertomarchalortega top2ainhibitionanditscellulareffectsrelatedtocellcyclecheckpointadaptationpathway